CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-04 | AYERS JONATHAN W Director | Gift | −1 | 145,519 | ||
| 2023-05-04 | Vandebroek Sophie V. Director | Option exercise | +2,187 | $206.62 | $452K | 3,059 |
| 2023-05-04 | Vandebroek Sophie V. Director | Sale | −2,187 | $469.02 | $1.0M | 872 |
| 2023-05-04 | Vandebroek Sophie V. Director | Gift | −500 | 8,173 | ||
| 2023-05-04 | Vandebroek Sophie V. Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,187 | 0 | ||
| 2023-05-04 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +560 | $178.26 | $100K | 73,301.35 |
| 2023-05-04 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Incentive Stock Option (right-to-buy) | −560 | 0 | ||
| 2023-04-28 | JUNIUS DANIEL M Director | Grant or award | +13 | $492.16 | $6K | 2,995 |
| 2023-02-16 | AYERS JONATHAN W Director | Gift | −1,000 | 145,520 | ||
| 2023-02-16 | JUNIUS DANIEL M Director | Option exercise | +2,187 | $206.62 | $452K | 5,169 |
| 2023-02-16 | JUNIUS DANIEL M Director | Sale | −2,187 | $511.68 | $1.1M | 2,982 |
| 2023-02-16 | JUNIUS DANIEL M Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,187 | 0 | ||
| 2023-02-16 | Turner Kathy V Senior Vice President | Option exercise | +10 | $79.54 | $795 | 7,389.85 |
| 2023-02-16 | Turner Kathy V Senior Vice President | Sale | −10 | $515.58 | $5K | 7,379.85 |
| 2023-02-16 | Turner Kathy V Senior Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −10 | 3,726 | ||
| 2023-02-15 | Turner Kathy V Senior Vice President | Grant or award | +1,000 | $79.54 | $80K | 8,379.85 |
| 2023-02-15 | Turner Kathy V Senior Vice President | Sale | −1,000 | $510.03 | $510K | 7,379.85 |
| 2023-02-15 | Turner Kathy V Senior Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,000 | 3,736 | ||
| 2023-02-14 | Underberg Sharon E. EVP, GC & Corp. Secretary | Option exercise | +483 | 3,524.99 | ||
| 2023-02-14 | Underberg Sharon E. EVP, GC & Corp. Secretary | Option exercise | +216 | 3,740.99 |
Page 45 of 52 · 1,036 trades